melatonin has been researched along with Proliferative Vitreoretinopathy in 2 studies
Excerpt | Relevance | Reference |
---|---|---|
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)." | 7.73 | Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006) |
"Melatonin is a known effective antitumour and anti-invasive agent, but whether it affects the formation and underlying mechanisms of PVR remains unclear." | 5.56 | Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy. ( Chen, PN; Chen, YS; Chien, HW; Chiou, HL; Hsieh, YH; Lee, CY; Lin, CL; Wang, K; Yang, SF, 2020) |
"To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR)." | 3.73 | Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin. ( Er, H; Mizrak, B; Parlakpinar, H; Turkoz, Y, 2006) |
"Melatonin is a known effective antitumour and anti-invasive agent, but whether it affects the formation and underlying mechanisms of PVR remains unclear." | 1.56 | Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy. ( Chen, PN; Chen, YS; Chien, HW; Chiou, HL; Hsieh, YH; Lee, CY; Lin, CL; Wang, K; Yang, SF, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Yang, SF | 1 |
Chen, YS | 1 |
Chien, HW | 1 |
Wang, K | 1 |
Lin, CL | 1 |
Chiou, HL | 1 |
Lee, CY | 1 |
Chen, PN | 1 |
Hsieh, YH | 1 |
Er, H | 1 |
Turkoz, Y | 1 |
Mizrak, B | 1 |
Parlakpinar, H | 1 |
2 other studies available for melatonin and Proliferative Vitreoretinopathy
Article | Year |
---|---|
Melatonin attenuates epidermal growth factor-induced cathepsin S expression in ARPE-19 cells: Implications for proliferative vitreoretinopathy.
Topics: Cathepsins; Cell Line; Cell Movement; Cell Proliferation; Epidermal Growth Factor; Gene Expression; | 2020 |
Inhibition of experimental proliferative vitreoretinopathy with protein kinase C inhibitor (chelerythrine chloride) and melatonin.
Topics: Alkaloids; Animals; Benzophenanthridines; Disease Models, Animal; Disease Progression; Drug Therapy, | 2006 |